AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionSummit Trail Advisors, Llc
Latest Disclosed Ownership64,582 shares
Latest Disclosed Value $ 14,045,930
Summit Trail Advisors, Llc reports 33.27% increase in ownership of ABBV / AbbVie Inc.

On May 12, 2026 - Summit Trail Advisors, Llc filed a 13F-HR form disclosing ownership of 64,582 shares of AbbVie Inc. (US:ABBV) valued at $14,045,939 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 48,458 shares of AbbVie Inc.. This represents a change in shares of 33.27% during the quarter. The current value of the position is $14,022,690 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE COM 00287Y109 64,582 16,124 33.27 14,046 26.85 0.2012
2026-02-17 2025-12-31 13F ABBVIE COM 00287Y109 48,458 -435 -0.89 11,072 -2.19 0.1914
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 48,893 5,855 13.60 11,321 41.71 0.1563
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 43,038 7,018 19.48 7,989 5.86 0.1371
2025-04-28 2025-03-31 13F ABBVIE COM 00287Y109 36,020 6,544 22.20 7,547 44.09 0.2490
2025-01-29 2024-12-31 13F ABBVIE COM 00287Y109 29,476 5,053 20.69 5,238 8.61 0.1933
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 24,423 3,865 18.80 4,823 36.76 0.1196
2024-08-13 2024-06-30 13F Abbvie Inc Com COM 00287Y109 20,558 2,924 16.58 3,526 9.81 0.0927
2024-04-23 2024-03-31 13F ABBVIE COM 00287Y109 17,634 -2,608 -12.88 3,211 2.39 0.0854
2024-02-06 2023-12-31 13F ABBVIE COM 00287Y109 20,242 920 4.76 3,137 8.89 0.1038
2023-10-30 2023-09-30 13F ABBVIE COM 00287Y109 19,322 1,801 10.28 2,880 22.03 0.1059
2023-07-25 2023-06-30 13F ABBVIE COM 00287Y109 17,521 10,856 162.88 2,361 122.22 0.0891
2023-05-04 2023-03-31 13F ABBVIE COM 00287Y109 6,665 400 6.38 1,062 4.94 0.0428
2023-02-07 2022-12-31 13F Abbvie Inc Com COM 00287Y109 6,265 402 6.86 1,012 28.59 0.0450
2022-11-10 2022-09-30 13F Abbvie Inc Com Stock 00287Y109 5,863 2,719 86.48 787 63.28 0.0426
2022-08-09 2022-06-30 13F Abbvie Inc Com COM 00287Y109 3,144 -17 -0.54 482 -5.86 0.0298
2022-05-16 2022-03-31 13F Abbvie Inc Com EQUITY 00287Y109 3,161 715 29.23 512 54.68 0.0414
2022-02-11 2021-12-31 13F Abbvie Inc Com Equity 00287Y109 2,446 43 1.79 331 27.80 0.0213
2021-11-16 2021-09-30 13F Abbvie Inc Com COM 00287Y109 2,403 2,403 259 0.0194
2021-02-16 2020-12-31 13F Expeditors Intl Wash Equity 00287Y109 0 -3,584 -100.00 0 -100.00
2020-11-16 2020-09-30 13F/A-1 Abbvie Inc Com Equity 00287Y109 3,584 3,584 354 0.0685
2020-11-16 2020-09-30 13F Expeditors Intl Wash Equity 00287Y109 362,713 31,835
2019-05-16 2019-03-31 13F ABBVIE INC COM EQUITY 00287Y109 0 -3,497 -100.00 0 -100.00
2019-02-13 2018-12-31 13F ABBVIE INC COM EQUITY 00287Y109 3,497 -3,724 -51.57 322 -52.86 0.1139
2018-11-14 2018-09-30 13F ABBVIE INC COM EQUITY 00287Y109 7,221 3,497 93.90 683 97.97 0.1507
2018-08-10 2018-06-30 13F Abbvie Inc Com EQUITY 00287Y109 3,724 -8,084 -68.46 345 -65.40 0.1206
2018-05-22 2018-03-31 13F/A-1 ABBVIE INC COM EQUITY 00287Y109 11,808 -1,081 -8.39 997 -25.26 0.1692
2018-05-21 2018-03-31 13F ABBVIE INC COM EQUITY 00287Y109 997,253 984,364 997
2018-02-14 2017-12-31 13F ABBVIE INC COM USD0.01 EQUITY 00287Y109 12,889 12,889 1,334 0.1685
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.